A Study to Test the Effect of Different Doses of BI 685509 on Kidney Function in People With Diabetic Kidney Disease
Public ClinicalTrials.gov record NCT04750577. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomised, Double-blind (Within Dose Groups), Placebo-controlled and Parallel Group Trial to Investigate the Effects of Different Doses of Oral BI 685509 Given Over 20 Weeks on UACR Reduction in Patients With Diabetic Kidney Disease
Study identification
- NCT ID
- NCT04750577
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Boehringer Ingelheim
- Industry
- Enrollment
- 243 participants
Conditions and interventions
Conditions
Interventions
- Placebo matching BI 685509 Drug
- BI 685509 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 26, 2021
- Primary completion
- Nov 29, 2022
- Completion
- Dec 26, 2022
- Last update posted
- Jul 22, 2024
2021 – 2022
United States locations
- U.S. sites
- 17
- U.S. states
- 11
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Kidney & Hypertension Center | Victorville | California | 92395 | — |
| Chase Medical Research, LLC | Waterbury | Connecticut | 06708 | — |
| Indago Research and Health Center | Hialeah | Florida | 33012 | — |
| Panax Clinical Research | Miami Lakes | Florida | 33014 | — |
| Davita Clinical Research | Columbus | Georgia | 31904 | — |
| Meridian Clinical Research, LLC | Savannah | Georgia | 31406 | — |
| Research by Design, LLC | Chicago | Illinois | 60643 | — |
| DaVita Clinical Research | Las Vegas | Nevada | 89128 | — |
| Total Renal Research | The Bronx | New York | 10461 | — |
| Brookview Hills Research Associates LLC | Winston-Salem | North Carolina | 27103 | — |
| Knoxville Kidney Center PLLC | Knoxville | Tennessee | 37923 | — |
| DaVita Clinical Research | Houston | Texas | 77054 | — |
| Texas Institute for Kidney and Endocrine Disorders | Lufkin | Texas | 75904 | — |
| Clinical Advancement Center, PLLC | San Antonio | Texas | 78212 | — |
| DaVita Clinical Research | San Antonio | Texas | 78240 | — |
| Kidney Specialists of North Houston, PLLC | Shenandoah | Texas | 77384 | — |
| Tidewater Kidney Specialists | Norfolk | Virginia | 23510 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 61 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04750577, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 22, 2024 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04750577 live on ClinicalTrials.gov.